• Title/Summary/Keyword: LCH

Search Result 84, Processing Time 0.023 seconds

Brand Marketing Strategy for Light Civil Helicopter (LCH) with Brand Asset Valuator (BAV) Model (BAV 모델을 적용한 소형 민수 헬기(LCH) 브랜드 커뮤니케이션 전략)

  • Ji Ho Park;Haeun Lee;Sanghak Lee
    • Journal of the Korean Society for Aviation and Aeronautics
    • /
    • v.32 no.2
    • /
    • pp.48-64
    • /
    • 2024
  • This study established a marketing strategy for the KAI Light Civil Helicopter (LCH) market by applying a Brand Asset Valuator (BAV) model to the LCH project currently underway by Korea Aerospace industries (KAI). Through literature reviews, the global scale of LCH projects and the development status of KAI LCH were identified. Subsequently, four sub-items from the BAV model were applied, and an expert survey was conducted. The primary data underwent an analysis process following the completion of the validity and reliability verification stage. The analysis revealed that the highest value was in the knowledge indicator, while the lowest value was in differentiation. The analysis confirmed KAI LCH's position on the BAV Power gird, indication that brand vitality, particularly differentiation, was lower than brand knowledge. Accordingly, this study finally presents a new marketing strategy to enhance the brand vitality of KAI LCH.

Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells

  • Seung-On Lee;Mee-Hyun Lee;Ah-Won Kwak;Jin-Young Lee;Goo Yoon;Sang Hoon Joo;Yung Hyun Choi;Jin Woo Park;Jung-Hyun Shim
    • Biomolecules & Therapeutics
    • /
    • v.31 no.6
    • /
    • pp.661-673
    • /
    • 2023
  • Treatment of colorectal cancer (CRC) has always been challenged by the development of resistance. We investigated the antiproliferative activity of licochalcone H (LCH), a regioisomer of licochalcone C derived from the root of Glycyrrhiza inflata, in oxaliplatin (Ox)-sensitive and -resistant CRC cells. LCH significantly inhibited cell viability and colony growth in both Ox-sensitive and Ox-resistant CRC cells. We found that LCH decreased epidermal growth factor receptor (EGFR) and AKT kinase activities and related activating signaling proteins including pEGFR and pAKT. A computational docking model indicated that LCH may interact with EGFR, AKT1, and AKT2 at the ATP-binding sites. LCH induced ROS generation and increased the expression of the ER stress markers. LCH treatment of CRC cells induced depolarization of MMP. Multi-caspase activity was induced by LCH treatment and confirmed by Z-VAD-FMK treatment. LCH increased the number of sub-G1 cells and arrested the cell cycle at the G1 phase. Taken together LCH inhibits the growth of Ox-sensitive and Ox-resistant CRC cells by targeting EGFR and AKT, and inducing ROS generation and ER stress-mediated apoptosis. Therefore, LCH could be a potential therapeutic agent for improving not only Ox-sensitive but also Ox-resistant CRC treatment.

Characterization of Anti-Listerial Substance Produced by Lactobacillus salivarius LCH1227 (Lactobacillus salivarius LCH1230으로부터 생산된 Listeria 균 억제물질의 특성)

  • Shin, Yu-Ri;Lim, Kong-Boon;Chae, Jong-Pyo;Kang, Dae-Kyung
    • Food Science of Animal Resources
    • /
    • v.31 no.4
    • /
    • pp.609-616
    • /
    • 2011
  • In this study, a LCH1227 bacterial strain that possesses anti-listerial activity was isolated from fermented food and identified as Lactobacillus salivarius LCH1227 based on its morphological and biochemical properties, as well as its 16S rRNA gene sequences. Anti-listerial substance also inhibited the growth of various Gram-positive bacteria, such as vancomycinresistant Enterococcus faecalis, Streptococcus agalactiae, Bacillus cereus, Lactobacillus fermentum. The highest level of production of antimicrobial substances from L. salivarius LCH1227 occurred during the early stationary phase. The antilisterial activity was found to be stable over a broad range of pH values (2.0-12.0) and after heat treatment. However, it was inactivated by proteolytic enzymes, indicating its proteinaceous nature. The apparent molecular mass of the partially purified anti-listerial substance, as measured by Tricine-SDS-PAGE, was approximately 5 kDa.

Licochalcone H Induces Cell Cycle Arrest and Apoptosis in Human Skin Cancer Cells by Modulating JAK2/STAT3 Signaling

  • Park, Kyung-Ho;Joo, Sang Hoon;Seo, Ji-Hye;Kim, Jumi;Yoon, Goo;Jeon, Young-Joo;Lee, Mee-Hyun;Chae, Jung-Il;Kim, Woo-Keun;Shim, Jung-Hyun
    • Biomolecules & Therapeutics
    • /
    • v.30 no.1
    • /
    • pp.72-79
    • /
    • 2022
  • Licochalcone H (LCH) is a phenolic compound synthetically derived from licochalcone C (LCC) that exerts anticancer activity. In this study, we investigated the anticancer activity of LCH in human skin cancer A375 and A431 cells. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assay was used to evaluate the antiproliferative activity of LCH. Cell cycle distribution and the induction of apoptosis were analyzed by flow cytometry. Western blotting assays were performed to detect the levels of proteins involved in cell cycle progression, apoptosis, and the JAK2/STAT3 signaling pathway. LCH inhibited the growth of cells in dose- and time-dependent manners. The annexin V/propidium iodide double staining assay revealed that LCH induced apoptosis, and the LCH-induced apoptosis was accompanied by cell cycle arrest in the G1 phase. Western blot analysis showed that the phosphorylation of JAK2 and STAT3 was decreased by treatment with LCH. The inhibition of the JAK2/STAT3 signaling pathway by pharmacological inhibitors against JAK2/STAT3 (cryptotanshinone (CTS) and S3I-201) simulated the antiproliferative effect of LCH suggesting that LCH induced apoptosis by modulating JAK2/STAT3 signaling.